NISA INVESTMENT ADVISORS, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$59,521
+129.7%
2,656
+317.0%
0.00%
Q2 2023$25,907
+31884.0%
637
-61.9%
0.00%
-100.0%
Q1 2023$81
+3.8%
1,670
-18.6%
0.00%0.0%
Q4 2022$78
-99.9%
2,051
-18.4%
0.00%0.0%
Q3 2022$99,000
+23.8%
2,514
+26.0%
0.00%0.0%
Q2 2022$80,000
+14.3%
1,996
+6.5%
0.00%
Q1 2022$70,000
-62.0%
1,875
-58.9%
0.00%
-100.0%
Q4 2021$184,000
+46.0%
4,565
+34.9%
0.00%0.0%
Q3 2021$126,000
-11.9%
3,3850.0%0.00%0.0%
Q2 2021$143,000
+19.2%
3,385
+33.5%
0.00%0.0%
Q1 2021$120,000
-22.6%
2,5350.0%0.00%0.0%
Q4 2020$155,000
+55.0%
2,535
+18.7%
0.00%0.0%
Q3 2020$100,000
+300.0%
2,135
+340.2%
0.00%
Q2 2020$25,000
+19.0%
485
+5.4%
0.00%
Q1 2020$21,000
+50.0%
460
+53.3%
0.00%
Q4 2019$14,000
+40.0%
3000.0%0.00%
Q3 2019$10,000
-28.6%
3000.0%0.00%
Q2 2019$14,000
+27.3%
3000.0%0.00%
Q1 2019$11,000
+10.0%
3000.0%0.00%
Q4 2018$10,000
-28.6%
3000.0%0.00%
Q3 2018$14,000
+40.0%
3000.0%0.00%
Q2 2018$10,000
-95.0%
300
-96.2%
0.00%
-100.0%
Q1 2018$201,000
+20.4%
7,800
-22.0%
0.00%0.0%
Q4 2017$167,000
-16.5%
10,0000.0%0.00%0.0%
Q3 2017$200,000
+60.0%
10,0000.0%0.00%
+100.0%
Q2 2017$125,000
+3025.0%
10,000
+1566.7%
0.00%
Q1 2016$4,0006000.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders